NCT06673498 Lusutrombopag Combined With Recombinant Human Thrombopoietin for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Destined to Undergo Elective Invasive Surgery Status RECRUITING Phase PHASE2
NCT06565364 Immunogenicity and Thrombotic Potential of Circulating Protamine-heparin Complexes in Cardiac Surgery Patients Status COMPLETED Phase N/A
NCT06562738 Clinical Study on Efficacy and Safety of Hetrombopag in the Preoperative Patients of Thrombocytopenia Status RECRUITING Phase PHASE4
NCT06521931 A Study of PN20 for the Prevention of Chemotherapy-induced Thrombocytopenia in Lymphoma or Solid Tumor Patients Status COMPLETED Phase PHASE1
NCT06491303 Effects of Levetiracetam Monotherapy on Various Hematological Parameters in Adult Patients Suffering of Epilepsy Status NOT_YET_RECRUITING Phase N/A
NCT06433830 Hetrombopag for the Thrombocytopenia Induced by Concurrent Chemoradiotherapy Status RECRUITING Phase PHASE2
NCT06349577 Optimizing Pulsatility During Cardiopulmonary Bypass to Reduce Acute Kidney Injury Status RECRUITING Phase NA
NCT06291415 The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP) Status WITHDRAWN Phase PHASE1
NCT06245746 UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia Status RECRUITING Phase PHASE1
NCT06202625 Efficacy and Safety of Avatrombopag in the Treatment of Thrombocytopenia After Haplo-HSCT Status RECRUITING Phase PHASE2/PHASE3
NCT06187831 Bleeding Events Before vs After Lowering Departmental Platelet Transfusion Trigger Status COMPLETED Phase N/A
NCT06095648 Study Comparing Platelet Transfusion Volumes in Premature Babies Status NOT_YET_RECRUITING Phase NA
NCT06036966 The Efficacy and Safety of Hetrombopag in Primary Prevention of Thrombocytopenia Induced by the Niraparib Maintenance in Advanced Ovarian Cancer Patients Status UNKNOWN Phase PHASE2
NCT06001567 Avatrombopag for HCC Patients With Thrombocytopenia Who Intend to Undergo TACE and/or HAIC Status UNKNOWN Phase PHASE2
NCT05998759 Telitacicept for the Treatment of Connective Tissue Disease-associated Thrombocytopenia Status RECRUITING Phase PHASE2
NCT05958511 Assessment of Risk Factors and Outcome of Thrombocytopenia in ICU Patients Status UNKNOWN Phase N/A